Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Iruretagoyena

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Mental Health (Abingdon, England)|March 15, 2023
Anti-stigma advocacy for health professionals: a systematic reviewZoe Guerrero, Barbara Iruretagoyena, Sarah Parry, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 17, 2020
Health State Utility Values in Schizophrenia: A Systematic Review and Meta-AnalysisDavid Aceituno, Mark Pennington, Barbara Iruretagoyena, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 12, 2021
Author's ReplyDavid Aceituno, Mark Pennington, Barbara Iruretagoyena, et al.
Evidence-Based Mental Health|May 26, 2019
Health state utility values in schizophrenia: protocol for a systematic review and meta-analysisDavid Aceituno, Mark Pennington, Barbara Iruretagoyena, et al.
Schizophrenia Research|March 13, 2018
Early treatment resistance in a Latin-American cohort of patients with schizophreniaCristian Mena, Alfonso Gonzalez-Valderrama, Barbara Iruretagoyena, et al.
Early Intervention in Psychiatry|January 16, 2019
High prevalence of metabolic alterations in Latin American patients at initial stages of psychosisBarbara Iruretagoyena, Carmen P Castañeda, Juan Undurraga, et al.
Schizophrenia Research|August 2, 2021
Predictors of clozapine discontinuation at 2 years in treatment-resistant schizophreniaBarbara Iruretagoyena, Carmen Paz Castañeda, Cristian Mena, et al.
Scientific Reports|November 4, 2021
Abnormal nodal and global network organization in resting state functional MRI from subjects with the 22q11 deletion syndromeTeuntje A D Pelgrim, Matthijs G Bossong, Analía Cuiza, et al.
Psychological Medicine|August 8, 2020
The incidence of non-affective psychotic disorders in Chile between 2005 and 2018: results from a national register of over 30 000 casesAlfonso González-Valderrama, Hannah E Jongsma, Cristián Mena, et al.
Schizophrenia Bulletin|December 21, 2021
Functional Dysconnectivity in Ventral Striatocortical Systems in 22q11.2 Deletion SyndromeÁngeles Tepper, Analía Cuiza, Luz María Alliende, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Mental Health (Abingdon, England)|March 15, 2023
Anti-stigma advocacy for health professionals: a systematic reviewZoe Guerrero, Barbara Iruretagoyena, Sarah Parry, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 17, 2020
Health State Utility Values in Schizophrenia: A Systematic Review and Meta-AnalysisDavid Aceituno, Mark Pennington, Barbara Iruretagoyena, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 12, 2021
Author's ReplyDavid Aceituno, Mark Pennington, Barbara Iruretagoyena, et al.
Evidence-Based Mental Health|May 26, 2019
Health state utility values in schizophrenia: protocol for a systematic review and meta-analysisDavid Aceituno, Mark Pennington, Barbara Iruretagoyena, et al.
Schizophrenia Research|March 13, 2018
Early treatment resistance in a Latin-American cohort of patients with schizophreniaCristian Mena, Alfonso Gonzalez-Valderrama, Barbara Iruretagoyena, et al.
Early Intervention in Psychiatry|January 16, 2019
High prevalence of metabolic alterations in Latin American patients at initial stages of psychosisBarbara Iruretagoyena, Carmen P Castañeda, Juan Undurraga, et al.
Schizophrenia Research|August 2, 2021
Predictors of clozapine discontinuation at 2 years in treatment-resistant schizophreniaBarbara Iruretagoyena, Carmen Paz Castañeda, Cristian Mena, et al.
Scientific Reports|November 4, 2021
Abnormal nodal and global network organization in resting state functional MRI from subjects with the 22q11 deletion syndromeTeuntje A D Pelgrim, Matthijs G Bossong, Analía Cuiza, et al.
Psychological Medicine|August 8, 2020
The incidence of non-affective psychotic disorders in Chile between 2005 and 2018: results from a national register of over 30 000 casesAlfonso González-Valderrama, Hannah E Jongsma, Cristián Mena, et al.
Schizophrenia Bulletin|December 21, 2021
Functional Dysconnectivity in Ventral Striatocortical Systems in 22q11.2 Deletion SyndromeÁngeles Tepper, Analía Cuiza, Luz María Alliende, et al.
Pageof 2